Oral Acarbose Market

Acarbose is a kind of API that is white powder,It is used to product such as acarbose tablets/acarbose capsules/acarbose chewable tablets which is a kind of - glucosidase inhibitor procucts. The medicine used drugs for type 2 diabetes, which is a pseudo-four sugar biosynthesis, can inhibit the small intestine cells activity of - glucosidase, thereby delaying intestinal oligosaccharide, disaccharide or polysaccharide degradation, delaying the degradation and absorption of glucose and fructose in order to achieve the effect of reducing postprandial blood glucose.

Oral Acarbose Market contains market size and forecasts of Oral Acarbose in global, including the following market information:

• Global Oral Acarbose Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Oral Acarbose Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Oral Acarbose companies in 2021 (%)

The global Oral Acarbose market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acarbose Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oral Acarbose include Bayer, CKDBioCorporation, Hangzhou East China Pharmaceutical, Livzon Pharmaceutical Group, Hebei Huarong Pharmaceutical, Zhejiang Hisun Pharmaceutical and Zhebei Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Acarbose manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Acarbose Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral Acarbose Market Segment Percentages, by Type, 2021 (%)

• Acarbose Tablets
• Acarbose Capsules
• Acarbose Chewable Tablets

Global Oral Acarbose Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral Acarbose Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Oral Acarbose Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oral Acarbose Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oral Acarbose revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Oral Acarbose revenues share in global market, 2021 (%)
• Key companies Oral Acarbose sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Oral Acarbose sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• CKDBioCorporation
• Hangzhou East China Pharmaceutical
• Livzon Pharmaceutical Group
• Hebei Huarong Pharmaceutical
• Zhejiang Hisun Pharmaceutical
• Zhebei Pharmaceutical